tomeko

Hirschsprung disease-nail hypoplasia-dysmorphism syndrome

Just diagnosed with Hirschsprung disease-nail hypoplasia-dysmorphism syndrome?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Hirschsprung disease-nail hypoplasia-dysmorphism syndrome, look for clinical trials, and connect with others living with it — all in one place.

Open the full Hirschsprung disease-nail hypoplasia-dysmorphism syndrome hub →

Overview

Hirschsprung disease-nail hypoplasia-dysmorphism syndrome is a rare condition. Also known as Al Gazali-Donnai-Muller syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Hirschsprung disease-nail hypoplasia-dysmorphism syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:2153 · OMIM 235760 · ICD-10 Q43.1 · GARD 0000584

Find care for Hirschsprung disease-nail hypoplasia-dysmorphism syndrome

Authoritative references for Hirschsprung disease-nail hypoplasia-dysmorphism syndrome

Common questions

I was just diagnosed with Hirschsprung disease-nail hypoplasia-dysmorphism syndrome — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Hirschsprung disease-nail hypoplasia-dysmorphism syndrome, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Hirschsprung disease-nail hypoplasia-dysmorphism syndrome?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Hirschsprung disease-nail hypoplasia-dysmorphism syndrome, filtered to your area.

Are there clinical trials for Hirschsprung disease-nail hypoplasia-dysmorphism syndrome?

Tomeko shows live, recruiting studies for Hirschsprung disease-nail hypoplasia-dysmorphism syndrome from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com